![Ho Sung Cho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ho Sung Cho
Director/Board Member at
California Biomedical Innovation Alliance
Profile
Ho Sung Cho is currently the Director at BIOCOM and the Director at California Biomedical Innovation Alliance.
Previously, he worked as the Associate Director-Protein Chemistry at Xencor, Inc., Director at Viron Therapeutics, Inc., Director at Boundless Bio, Inc., Vice President-Biotherapeutics at Celgene Corp., Team Leader at Exelixis, Inc., Vice President-Technology & Process Development at Ambrx, Inc., Staff Scientist at Lawrence Berkeley National Laboratory, and Medicinal Chemist at Burroughs Wellcome.
He holds a doctorate degree from the University of California.
Ho Sung Cho active positions
| Companies | Position | Start |
|---|---|---|
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Director/Board Member | 2017-08-27 |
Former positions of Ho Sung Cho
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 2019-10-31 |
| BOUNDLESS BIO, INC. | Director/Board Member | - |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Director/Board Member | - |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Director/Board Member | - |
Burroughs Wellcome | Corporate Officer/Principal | - |
Training of Ho Sung Cho
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Lawrence Berkeley National Laboratory
 Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Researches on environmental studies, nanoscience and quantitative biology, physics and nuclear energy | Commercial Services |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Health Technology |
Burroughs Wellcome | |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Ho Sung Cho
